Zydus Therapeutics Inc.
Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.
-
Fatty liver drug trial in PCOS women halted early
Disease control TerminatedThis study tested a drug called saroglitazar in women with polycystic ovary syndrome (PCOS) who also had nonalcoholic fatty liver disease (NAFLD). The goal was to see if the drug could reduce liver fat over 24 weeks compared to a placebo. The trial was terminated early, so result…
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Fatty liver drug trial in HIV patients halted early
Disease control TerminatedThis study tested a drug called saroglitazar magnesium to reduce liver fat in people with both HIV and nonalcoholic fatty liver disease (NAFLD). Only 4 adults enrolled before the trial was stopped early. The goal was to see if the drug could safely lower liver fat compared to a p…
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC